The Island of Misfit Stocks: Cash Cows and SleepwalkersGlobal Report·Jul 22 at 04:18 AMRGC-5.36%LKFT-1.53%
Lakefront Announces Paulo Fontoura has Resigned from its Board following his Appointment as Global Head of R&D at SanofiUnusual Whales·Jul 13 at 03:03 PMLKFT-1.53%SNY-1.52%
Lakefront Biotherapeutics director Paulo Fontoura steps down after taking Sanofi R&D chief rolePUBT·Jul 13 at 03:01 PMLKFT-1.53%SNY-1.52%
Lakefront Biotherapeutics Buys Back Over 104,000 Shares Under June 2026 Repurchase ProgramTip Ranks·Jul 7 at 03:47 PMLKFT-1.53%
Lakefront Receives Transparency Notification from Madison Avenue PartnersUnusual Whales·Jun 29 at 03:02 PMLKFT-1.53%
Madison Avenue Partners discloses 5.31% stake in Lakefront BiotherapeuticsPUBT·Jun 29 at 03:01 PMLKFT-1.53%
Lakefront Biotherapeutics repurchases own stock for EUR 1.92 millionPUBT·Jun 23 at 03:01 PMLKFT-1.53%
Lakefront Appoints Eric Hedrick, MD, as Chief Medical OfficerUnusual Whales·Jun 8 at 03:03 PMLKFT-1.53%
Gilead Sciences and Lakefront Complete Acquisition of Ouro Medicines to Further Expand Inflammation Pipeline | GILD Stock NewsStockTitan·Jun 4 at 07:15 AMGILD-1.18%LKFT-1.53%
RBC Capital Sticks to Its Hold Rating for Lakefront Biotherapeutics (LKFT)Tip Ranks·May 13 at 06:47 AMLKFT-1.53%
Galapagos Shareholders Approve Name Change to Lakefront Biotherapeutics and Broad Governance OverhaulTip Ranks·Apr 29 at 08:38 AMGLPG0.00%BBH-0.69%
